Literature DB >> 11219170

Levels and avidity of antibodies to tetanus toxoid in children aged 1-15 years in Dar es Salaam and Bagamoyo, Tanzania.

S Aboud1, R Matre, E F Lyamuya, E K Kristoffersen.   

Abstract

A study was undertaken to determine the serological response in children (aged 1-15 years) immunized with diphtheria-pertussis-tetanus vaccine (DPT) alone or with a tetanus toxoid (TT) booster dose under the Expanded Programme on Immunization in Dar es Salaam and Bagamoyo, Tanzania. Using an ELISA technique, serum levels of anti-TT antibody, antibody avidity and anti-TT IgG subclasses were determined in 138 apparently healthy children. Our findings revealed that 94.7% and 98% of children aged 1-5 years in Dar es Salaam and Bagamoyo, respectively, had anti-TT antibody levels above that considered protective (> or = 0.1 IU/ml). Among 6-15-year-old children, 53.3% in Dar es Salaam and 55% in Bagamoyo had anti-TT antibody levels > or = 0.1 IU/ml. The avidity index of anti-TT antibodies was high in most of the younger children, 84.2% in Dar es Salaam and 92% in Bagamoyo. Significantly fewer older children in Dar es Salaam and Bagamoyo (53.3% and 50%, respectively) had high avidity index antibodies. The predominant anti-TT IgG subclasses were IgG1 and IgG3. It is concluded that the current DPT immunization schedule provides adequate tetanus immunity for children under 5. However, about half of the older children had no protection against tetanus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11219170     DOI: 10.1080/02724936.2000.11748153

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  6 in total

1.  Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique.

Authors:  Heather M Scobie; Minal Patel; Diana Martin; Harran Mkocha; Sammy M Njenga; Maurice R Odiere; Sonia Pelletreau; Jeffrey W Priest; Ricardo Thompson; Kimberly Y Won; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2016-12-05       Impact factor: 2.345

2.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

3.  Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013-2014.

Authors:  Alvan Cheng; Angie Ghanem-Uzqueda; Nicole A Hoff; Hayley Ashbaugh; Reena H Doshi; Patrick Mukadi; Roger Budd; Stephen G Higgins; Christina Randall; Sue Gerber; Michel Kabamba; Guilluame Ngoie Mwamba; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tanfum; Anne W Rimoin
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

4.  Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme.

Authors:  Lenesha Warrener; Josephine Bwogi; Nick Andrews; Dhanraj Samuel; Theopista Kabaliisa; Henry Bukenya; Kevin Brown; Martha H Roper; David A Featherstone; David Brown
Journal:  Epidemiol Infect       Date:  2018-05-09       Impact factor: 4.434

Review 5.  Eradication of tetanus.

Authors:  C L Thwaites; H T Loan
Journal:  Br Med Bull       Date:  2015-11-22       Impact factor: 4.291

6.  Tetanus in Southern Vietnam: Current Situation.

Authors:  Duong Bich Thuy; James I Campbell; Tran Tan Thanh; Cao Thu Thuy; Huynh Thi Loan; Nguyen Van Hao; Yen Lam Minh; Le Van Tan; Maciej F Boni; C Louise Thwaites
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.